Cargando…
RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment
Nearly one-third of adults in the U.S. have hypertension, which is associated with increased cardiovascular disease (CVD) morbidity and mortality. The goal of antihypertensive pharmacogenetic research is to enhance understanding of drug response based on the interaction of individual genetic archite...
Autores principales: | Lynch, Amy I, Irvin, Marguerite R, Boerwinkle, Eric, Davis, Barry R, Vaughan, Laura K, Ford, Charles E., Aissani, Brahim, Eckfeldt, John H, Arnett, Donna K, Shrestha, Sadeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435442/ https://www.ncbi.nlm.nih.gov/pubmed/22664477 http://dx.doi.org/10.1038/tpj.2012.22 |
Ejemplares similares
-
The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study
por: Do, Anh N., et al.
Publicado: (2014) -
Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHAT
por: Lynch, Amy I., et al.
Publicado: (2013) -
The effects of genes implicated in cardiovascular disease on blood-pressure response to treatment among treatment-naïve hypertensive African Americans in the GenHAT study
por: Do, Anh N, et al.
Publicado: (2016) -
Pharmacogenetic Association of NOS3 Variants with Cardiovascular Disease in Patients with Hypertension: The GenHAT Study
por: Zhang, Xue, et al.
Publicado: (2012) -
Pharmacogenetic Associations of MMP9 and MMP12 Variants with Cardiovascular Disease in Patients with Hypertension
por: Tanner, Rikki M., et al.
Publicado: (2011)